Literature DB >> 35086941

CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab.

Michel Dominique Ferrari1, Gisela Marie Terwindt1, Antoinette MaassenVanDenBrink2, Simone de Vries Lentsch1, Linda Al-Hassany3.   

Abstract

Entities:  

Keywords:  migraine; trigeminal nerve

Mesh：

Substances：

Year:  2022        PMID： 35086941     DOI： 10.1136/jnnp-2021-327992

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   13.654


× No keyword cloud information.
  1 in total

1.  Serum CGRP in migraine patients using erenumab as preventive treatment.

Authors:  Gisela M Terwindt; Antoinette MaassenVanDenBrink; Simone de Vries Lentsch; Ingrid M Garrelds; A H Jan Danser
Journal:  J Headache Pain       Date:  2022-09-12       Impact factor: 8.588
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.